15 / 68
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 3, May/June 2015
AFRICA
113
879–888.
15. Quinn SF, Gosink BB. Characteristic sonographic signs of hepatic fatty
infiltration.
Am J Roentgenol
1985;
145
: 753–755.
16. Joseph AE, Saverymuttu SH, al-Sam S,
et al
. Comparison of liver histol-
ogy with ultrasonography in assessing diffuse parenchymal liver disease.
Clin Radiol
1991;
43
: 26–31.
17. Needleman L, Kurtz AB, Rifkin MD,
et al
. Sonography of diffuse
benign liver disease: accuracy of pattern recognition and grading.
Am J
Roentgenol
1986;
146
: 1011–1015.
18. Fallo F, Dalla Pozza A, Sonino N,
et al
. Non-alcoholic fatty liver disease
is associated with left ventricular diastolic dysfunction in essential
hypertension.
Nutr Metab Cardiovasc Dis
2009;
19
: 646–653.
19. Goland S, Shimoni S, Zornitzki T,
et al
. Cardiac abnormalities as a new
manifestation of nonalcoholic fatty liver disease: echocardiographic
and tissue Doppler imaging assessment.
J Clin Gastroenterol
2006;
40
:
949–955.
20. Bonapace S, Perseghin G, Molon G,
et al
. Nonalcoholic fatty liver
disease is associated with left ventricular diastolic dysfunction in
patients with type 2 diabetes.
Diabetes Care
2012;
35
: 389–395.
21. Tei C. New non-invasive index for combined systolic and diastolic
venricular function.
J Cardiol
1995;
26
: 135–136.
22. Kang SM, Ha JW, Rim SJ,
et al.
Index of myocardial performance
using Doppler-derived parameters in the evaluation of left ventricular
function in patients with essential hypertension.
Yonsei Med J
1998;
39
: 446–452.
23. Saadeh S, Younossi ZM, Remer EM,
et al
. The utility of radiological
imaging in nonalcoholic fatty liver disease.
Gastroenterology
2002;
123
:
745–750.